#PittPharmacyInSpace

Antimicrobial resistance is a growing public health issue that has a global and even a universal effect.

With the concurrently increasing frequency, duration, and overall ambition of space exploration, it is important to approach the treatment of infections during spaceflight with confidence and precision.

A closed, high-touch environment aboard the International Space Station and other space vessels, combined with increased bacterial virulence and human immunosuppression during spaceflight further highlight the importance of research into antimicrobial therapies under microgravity conditions.

Specifically, this experiment will explore whether or not survival responses previously shown during spaceflight are antibiotic-specific or broadly attributable to other antibiotics.

This will provide data towards constructing evidence-based guidelines for the treatment of infectious disease during spaceflight, as well as provide insight into mechanisms of antimicrobial resistance for drug development on Earth.

In doing so, we can make space and Earth safer for all.